DUBLIN--(http://www.researchandmarkets.com/research/5cpl3q/global_erectile) has announced the addition of the "Global Erectile Dysfunction Drug Pipeline Capsule - 2012 Update" report to their offering.)--Research and Markets (
“Global Erectile Dysfunction Drug Pipeline Capsule - 2012 Update”
Fore Pharma's latest report 'Global Erectile Dysfunction Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Erectile Dysfunction market. It covers active Erectile Dysfunction pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Features of the Report:
- Erectile Dysfunction: Overview
- Erectile Dysfunction Pipeline Overview
- Erectile Dysfunction Phase 3 Clinical Trial Pipeline Insights
- Erectile Dysfunction Phase 2 Clinical Trial Pipeline Insights
- Erectile Dysfunction Phase 1 Clinical Trial Pipeline Insights
- Erectile Dysfunction Preclinical Research Pipeline Insights
- Erectile Dysfunction Discovery Stage Pipeline Insights
- Geographic Landscape of Erectile Dysfunction R&D Activities
- Erectile Dysfunction R&D Activities in North America
- Erectile Dysfunction R&D Activities in Europe
- Licensing Activities / Partnerships
For more information visit http://www.researchandmarkets.com/research/5cpl3q/global_erectile